From sgRNA Design to a Verified Guide Vector
A CRISPR guide cloning record is a traceable link between the biological target, selected guide sequence, protocol-specific oligos, destination vector, physical clone, and verification evidence. It prevents the guide used in an experiment from becoming detached from the design assumptions and plasmid version that produced it.
The workflow should be documented from target definition through vector approval. Because guide design, oligo construction, cloning, and edit validation answer different questions, each stage needs its own identifiers, review criteria, and evidence rather than one generic “CRISPR plasmid” entry.
Start with the biological question and target reference
Before recording a guide sequence, define the intended manipulation, target gene or locus, reference assembly and transcript where relevant, cell or organism context, nuclease or editor, and delivery strategy. These choices determine which target sequences are valid and how downstream results will be interpreted.
ZettaCRISPR is positioned by Zettalab as a tool for guide RNA and sequencing-primer design before the wet-lab step. The design output can be connected with ZettaGene sequence context and ZettaNote experiment records through the Zettalab R&D workspace. The record should still preserve the exact reference version and design settings used for each candidate.
Separate the guide sequence from cloning oligos
The biological guide sequence is not always identical to the oligonucleotides ordered for cloning. Protocol-specific oligos may add compatible ends, exclude the PAM, introduce an extra transcription-initiation base, or require a particular orientation. The applicable rules depend on the destination vector and protocol, so the record must distinguish the designed guide from the final supplier-facing oligos.
| Record object | Required context | Approval question |
|---|---|---|
| Target reference | Assembly, gene, transcript, locus coordinates, and sequence version | Is the biological target unambiguous? |
| Guide candidate | Spacer sequence, nuclease, PAM context, strand, scores, and design settings | Was the guide selected using documented criteria? |
| Cloning oligos | Exact 5′ to 3′ sequences, added ends, orientation, and protocol | Are the ordered oligos compatible with the chosen vector? |
| Destination vector | Backbone ID, version, cloning site, selectable features, and source | Does the vector match the guide-expression strategy? |
| Verified clone | Physical ID, expected sequence, screening, sequencing, and reviewer | Does the plasmid contain the intended guide insert? |
Preserve guide-selection rationale
Save the candidate set or enough evidence to explain why one guide was selected. Relevant factors can include target position, predicted specificity, on-target score, off-target review, functional region, isoform considerations, and experimental constraints. Scores are model-dependent, so the record should include the tool, reference data, and date or version used rather than treating a number as universally comparable.
Control the destination vector and expected sequence
The vector record should identify the exact backbone version, guide-cloning site, promoter or expression strategy, selectable marker, and source. If the protocol is associated with a specific deposited plasmid, preserve the protocol version and verify the current sequence rather than relying on a shorthand vector name.
Before oligos are ordered, create the expected post-cloning plasmid sequence. Confirm the guide insert orientation, retained flanking bases, promoter-to-guide relationship, and any scaffold or constant region that must remain unchanged. Candidate resources in the Zettalab Plasmid Library may support vector discovery, but researchers must verify sequence, availability, licensing, and experimental suitability.
Issue new versions when the guide or backbone changes
A one-base change in the spacer, an alternative transcript reference, or a revised backbone can change the scientific object. Do not overwrite the previous design. Create a new guide or construct version, link it to the reason for revision, and mark superseded oligos and clones clearly. This protects experiments from using material that shares a familiar name but represents a different design.
Document the cloning experiment as an evidence chain
The experiment record should reference the guide design ID, oligo stock IDs, vector lot or preparation, protocol, reaction conditions, transformation or screening steps, candidate clone IDs, and expected product. It should also capture deviations, failed candidates, and reviewer decisions rather than preserving only the successful clone.
The Zettalab guide describes sequence files, primers, molecular cloning, alignment, shared libraries, and ELN records as connected workflows. This model is useful for CRISPR guide cloning because the same design must move from sequence analysis into a physical vector and then into a documented experiment.
Verify the vector before interpreting editing outcomes
Screen candidate colonies using a method appropriate to the vector and protocol, then sequence the guide insertion region. Compare the result with the approved expected plasmid, checking the full inserted guide, orientation, flanking bases, and any region that may have been altered during cloning. Approve the physical clone only after the evidence is reviewed and linked to its material identifier.
Keep vector verification separate from edit validation
A correct guide plasmid proves that the delivery construct matches the design; it does not prove that the intended genomic edit occurred. Downstream validation may use DNA-, RNA-, or protein-level methods depending on the experimental goal. Link those results to the exact guide and vector version used, while keeping the approval states separate so construct identity is not confused with biological performance.
A practical ELN section structure
- Target definition: Biological question, reference sequence, locus, nuclease, and intended edit.
- Guide decision: Candidate set, selected spacer, PAM context, settings, and reviewer rationale.
- Cloning design: Vector version, oligo sequences, protocol, and expected plasmid sequence.
- Wet-lab execution: Materials, reaction, deviations, candidate clones, and screening results.
- Approval and use: Sequence verification, approved clone ID, downstream experiments, and edit-validation links.
FAQ
What information should be stored with an sgRNA design?
Store the spacer sequence, nuclease or editor, PAM context, target strand, genomic assembly, gene or transcript reference, coordinates, and design-tool settings. Preserve relevant on-target and off-target review outputs with the tool and data version used. Record the biological rationale for selecting the guide, including any functional-region or isoform considerations. The cloning oligos should be separate objects because they may add vector-specific ends or transcription-related bases. Finally, link the guide to the destination vector, expected plasmid, physical clone, and experiments that used it.
Is the PAM included in guide-cloning oligos?
Not necessarily. The PAM is part of the genomic targeting context recognized by the nuclease, but whether it appears in the ordered oligos depends on the vector and cloning protocol. Many guide-expression cloning workflows order only the spacer plus protocol-specific ends, while other systems have different requirements. Follow the current protocol associated with the exact destination vector. The record should show the genomic target with PAM context, the selected spacer, and the final ordered oligos as separate fields so no one has to infer which bases were included.
How do you verify a CRISPR guide plasmid?
First create an expected plasmid sequence from the controlled backbone and selected guide. Screen candidate clones using a method suitable for the vector, then sequence the guide insertion region. Confirm the complete spacer, orientation, flanking bases, and unchanged constant elements around the cloning site. Compare the read with the expected sequence and preserve the raw data, alignment, physical clone ID, reviewer, and decision. Vector verification confirms construct identity; downstream genomic, RNA, or protein assays are still needed to evaluate whether the intended biological edit occurred.
Why is guide RNA version control important?
Guide designs can change when reference assemblies, transcripts, scoring methods, target strategies, or backbones change. A small sequence revision may produce a different biological reagent even when the project name remains the same. Version control preserves the relationship among the target reference, selected spacer, cloning oligos, expected vector, physical clone, and downstream result. It also prevents obsolete oligos or plasmids from being used after a design update. New nucleotide sequences should receive a new controlled version or identifier rather than replacing earlier records in place.
Conclusion
CRISPR guide cloning documentation should connect target intent with guide selection, protocol-specific oligos, a controlled vector, verified physical material, and downstream validation. Separate each object, preserve version history, and require evidence at the correct stage. Teams can explore ZettaCRISPR, ZettaGene, and ZettaNote for a connected gene-editing workflow.